Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to research in oncology and bacterial infections in order to improving patient outcomes and quality of life.
Our main activities include drug development, drug manufacturing and digital health investment. Debiopharm International SA aims to develop innovative therapies that target high unmet medical needs.
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.
Debiopharm International S.A. identifies high-potential compounds for in-licensing, conducts clinical development and then selects large pharmaceutical commercialization partners to maximize patient access across the globe.
For our Clinical Safety and Pharmacovigilance team in the Research and Development department based in Lausanne we are looking for a :
Safety Physician, Oncology Early Phases (100%)
In this role, you will be responsible for actively managing and evaluating risks associated with products in development, mostly in Early Phases in oncology innovative products such as Radiopharmaceutical products.
This role reports to the Head of Clinical Safety and Pharmacovigilance.
Your responsibilities will be but not limited to :